Showing results (3051-3060 of 6,239) with videos related to
Sort By:
Pageof 624
Nature Medicine|August 11, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancerIda Aronchik, Sumit Kar, Yongxian Zhuang, et al.Nature Medicine|September 10, 2026
Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trialLars H Lund, Carolyn S P Lam, Patricia Ely Pizzato, et al.Nature Medicine|September 10, 2026
COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancerJoe-Elie Salem, Raphaelle Curmin, Aya Ajrouche, et al.Nature Medicine|August 18, 2026
Emergence and spread of Plasmodium falciparum PX1 polymorphisms associated with decreased susceptibility to antimalarials in UgandaKaramoko Niaré, Bersabeh Tafesse, Mayland Treat, et al.Nature Medicine|September 29, 2026
Reproducibility in biomedical researchJudy Zhong, Debra D'Angelo, Chen Lyu, et al.Nature Medicine|September 29, 2026
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trialMiao Yu, Liang Peng, Chengyan Jiang, et al.Nature Medicine|September 22, 2026
Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligenceJian Zhou, Guangyu Guo, Jiawen Yao, et al.Nature Medicine|September 16, 2026
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trialXinghao Ai, Zhengbo Song, Lin Wu, et al.Nature Medicine|October 13, 2026
Human-artificial intelligence collaboration for comanaging epilepsy in real timeZack Goldblum, Haoer Shi, Zhongchuan Xu, et al.Nature Medicine|October 14, 2026
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trialMacLean C Sellars, Jessica A Frank, Bohoon Shim, et al.Pageof 624